Does ENZALUTAMIDE Cause Metastases to bone? 337 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 337 reports of Metastases to bone have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.7% of all adverse event reports for ENZALUTAMIDE.
337
Reports of Metastases to bone with ENZALUTAMIDE
0.7%
of all ENZALUTAMIDE reports
28
Deaths
69
Hospitalizations
How Dangerous Is Metastases to bone From ENZALUTAMIDE?
Of the 337 reports, 28 (8.3%) resulted in death, 69 (20.5%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 337 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which ENZALUTAMIDE Alternatives Have Lower Metastases to bone Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE